| Common Name | 7F3com-2H2, MEDI-528 |
|---|---|
| Synonyms | Interleukin-9;IL-9;Cytokine P40;T-cell growth factor P40 |
| Applications | ELISA; Flow Cyt |
| Recommended Dilutions | ELISA 1:5000-10000; Flow Cyt 1:100 |
| Formulation & Reconstitution | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| Host Species | Humanized |
| IgG type | IgG1 |
| Reactivity | Human |
| Target | |
| Uniprot ID | P15248 |
| Description | Anti-IL9(enokizumab biosimilar) mAb |
| Delivery | In Stock |
| Storage & Shipping | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
| Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Usage | Research use only |
Anti-IL9(enokizumab biosimilar) mAb
Price: 50μg $82.00 ; 100 μg $162.00
Product Data
Images
Figure 1. ELISA plate pre-coated by 1 μg/mL (100 μL/well) Cynomolgus IL9 Protein, hFc Tag (PME-C100003) can bind Anti-IL9 Neutralizing antibody (BME100122) in a linear range of 2.44–156.25 ng/mL. In order to specifically detect BME100122, mouse anti-human Fab-specific antibody was used as detection antibody.
Figure 2. Flow cytometry analysis under cell membrane permeable condition with 1 μg/mL Anti-IL9 (enokizumab biosimilar) mAb (BME100122) on Expi293 cells transfected with Human IL9 protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).